The Beauty Health Company - Class A Common Stock (SKIN)

Beauty Health (SKIN) Q4 2025 Earnings Transcript

LONG BEACH, Calif., March 12, 2026 (GLOBE NEWSWIRE) -- The Beauty Health Company (NASDAQ: SKIN) (“BeautyHealth” or the "Company"), home to flagship brand Hydrafacial, today announced financial results for the full year and fourth quarter ended December 31, 2025 (“Q4 2025”).

The Hydrafacial Treatment and SkinStylus Nano-Channeling Protocol Addresses Rising Consumer Demand for Combination Treatments That Can Improve Performance and Enhance Results

LONG BEACH, Calif., Feb. 26, 2026 (GLOBE NEWSWIRE) -- The Beauty Health Company (NASDAQ:SKIN), home to flagship brand Hydrafacial™, today announced it will report fourth quarter and full year 2025 financial results after market close on Thursday, March 12, 2026. The Company will host an investor conference call at 4:30 p.m. Eastern Time, following a press release detailing the results.

The Russell 2000 (^RUT) is packed with potential breakout stocks, thanks to its focus on smaller companies with high growth potential. However, smaller size also means these businesses often lack the resilience and financial flexibility of large-cap firms, making careful selection crucial.

A highly volatile stock can deliver big gains - or just as easily wipe out a portfolio if things go south. While some investors embrace risk, mistakes can be costly for those who aren’t prepared.

The end of the earnings season is always a good time to take a step back and see who shined (and who not so much). Let’s take a look at how personal care stocks fared in Q3, starting with Nature's Sunshine (NASDAQ:NATR).

Unprofitable companies face headwinds as they struggle to keep operating expenses under control. Some may be investing heavily, but the majority fail to convert spending into sustainable growth.

The stocks in this article have caught Wall Street’s attention in a big way, with price targets implying returns above 20%. But investors should take these forecasts with a grain of salt because analysts typically say nice things about companies so their firms can win business in other product lines like M&A advisory.

Latest volume reveals how shifting consumer preferences are redefining modern aesthetics

Small-cap stocks can be incredibly lucrative investments because their lack of analyst coverage leads to frequent mispricings. However, these businesses (and their stock prices) often stay small because their subscale operations make it harder to expand their competitive moats.

Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq., a partner at the law firm of Kahn Swick & Foti, LLC (“KSF”), announces that KSF has commenced an investigation into The Beauty Health Company (“Beauty Health” or the “Company”) (NasdaqCM: SKIN).

Earnings results often indicate what direction a company will take in the months ahead. With Q3 behind us, let’s have a look at BeautyHealth (NASDAQ:SKIN) and its peers.

Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq., a partner at the law firm of Kahn Swick & Foti, LLC (“KSF”), announces that KSF has commenced an investigation into The Beauty Health Company (“Beauty Health” or the “Company”) (NasdaqCM: SKIN).

BeautyHealth’s third quarter saw the company outperform Wall Street’s revenue expectations, despite a double-digit year-over-year sales decline. The market’s positive reaction reflected management’s focus on stabilizing the core Hydrafacial business and shifting to higher-margin recurring consumables. CEO Pedro Malha credited “strong operational execution and disciplined cost management” for improved operating margins, as well as the successful transition to a distributor model in China, which helped streamline inventory and reduce exposure to tariffs. Management highlighted booster product innovation and a growing installed device base as bright spots, even as device sales remained pressured by cautious consumer spending and financing challenges.

Stocks trading in the $1-10 range are generally smaller players with less risk than their penny stock counterparts. But that doesn’t mean the underlying businesses are cheap, and we advise caution as many have questionable fundamentals.

Shares of skincare company BeautyHealth (NASDAQ:SKIN) jumped 4.3% in the afternoon session after the company reported third-quarter 2025 financial results that showed improved profitability and an increased full-year outlook, even as sales declined. 

Skincare company BeautyHealth (NASDAQ:SKIN) reported revenue ahead of Wall Streets expectations in Q3 CY2025, but sales fell by 10.3% year on year to $70.66 million. The company’s full-year revenue guidance of $296.5 million at the midpoint came in 0.8% above analysts’ estimates. Its GAAP loss of $0.09 per share was in line with analysts’ consensus estimates.

BeautyHealth (SKIN) stock surged over 16% after Q3 2025 results beat revenue estimates and showed strong profitability improvements.

Skincare company BeautyHealth (NASDAQ:SKIN) reported revenue ahead of Wall Streets expectations in Q3 CY2025, but sales fell by 10.3% year on year to $70.7 million. The company’s full-year revenue guidance of $296.5 million at the midpoint came in 0.8% above analysts’ estimates. Its GAAP loss of $0.09 per share was in line with analysts’ consensus estimates.

Discover the top movers in Thursday's after-hours session and stay informed about the post-market dynamics.

LONG BEACH, Calif., Nov. 06, 2025 (GLOBE NEWSWIRE) -- The Beauty Health Company (NASDAQ: SKIN) (“BeautyHealth” or the "Company"), home to flagship brand Hydrafacial, today announced financial results for the third quarter ended September 30, 2025 (“Q3 2025”).

Skincare company BeautyHealth (NASDAQ:SKIN) will be announcing earnings results this Thursday after market hours. Here’s what investors should know.